Is Denali Therapeutics Inc. (DNLI) a Buy, Sell, or Hold?
Denali Therapeutics Inc.
NASDAQ:DNLI
$22.65 USD
-$3.83 (-14.46%)
- Volume
- 5.78M
- Average Volume
- 1.83M
- Market Capitalization
- $3.59B
- P/E Ratio
- -7.86
- Dividend Yield
- 0.00%
- Price Target
- $35.00
- Year High
- $27.30
- Year Low
- $12.58
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.28
DNLI vs. The Competition
| Properties | DNLI | AGIO | BEAM | COGT |
|---|---|---|---|---|
| Market Cap | $3.59B | $2.37B | $3.18B | $6.58B |
| Shares Outstanding | $158.71M | $59.47M | $102.88M | $170.87M |
| P/E Ratio | -7.86 | -5.51 | -48.27 | -12.5 |
| EPS | -2.72 | -7.19 | -0.63 | -5.26 |
| Day Low | 22.03 | 39.49 | 29.9 | 37.04 |
| Day high | 26.32 | 40.48 | 31.545 | 38.635 |
| Year Low | 12.58 | 22.24 | 15.6 | 10.38 |
| Year High | 27.3 | 46 | 38.26 | 43.73 |
| Average Price 50 | 21.7054 | 31.7174 | 31.6016 | 35.1177 |
| Average Price 200 | 19.23908 | 31.8565 | 27.9649 | 33.01745 |
| Volume | 5.78M | 672.96K | 2.01M | 2.08M |
| Average Volume | - | - | - | - |